JP2014110814A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014110814A5 JP2014110814A5 JP2014057616A JP2014057616A JP2014110814A5 JP 2014110814 A5 JP2014110814 A5 JP 2014110814A5 JP 2014057616 A JP2014057616 A JP 2014057616A JP 2014057616 A JP2014057616 A JP 2014057616A JP 2014110814 A5 JP2014110814 A5 JP 2014110814A5
- Authority
- JP
- Japan
- Prior art keywords
- human
- mouse
- gene
- gene segment
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000623 proteins and genes Proteins 0.000 claims 89
- 210000004027 cell Anatomy 0.000 claims 23
- 238000003780 insertion Methods 0.000 claims 14
- 230000037431 insertion Effects 0.000 claims 14
- 101000998953 Homo sapiens Immunoglobulin heavy variable 1-2 Proteins 0.000 claims 7
- 102100036887 Immunoglobulin heavy variable 1-2 Human genes 0.000 claims 7
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 7
- 239000000427 antigen Substances 0.000 claims 7
- 102000036639 antigens Human genes 0.000 claims 7
- 108091007433 antigens Proteins 0.000 claims 7
- 150000007523 nucleic acids Chemical group 0.000 claims 7
- 210000003719 b-lymphocyte Anatomy 0.000 claims 6
- 238000000034 method Methods 0.000 claims 5
- 210000004408 hybridoma Anatomy 0.000 claims 4
- 102000004169 proteins and genes Human genes 0.000 claims 4
- 238000011144 upstream manufacturing Methods 0.000 claims 4
- 210000001161 mammalian embryo Anatomy 0.000 claims 3
- 101710098119 Chaperonin GroEL 2 Proteins 0.000 claims 2
- 108020004414 DNA Proteins 0.000 claims 2
- 238000012258 culturing Methods 0.000 claims 2
- 210000001671 embryonic stem cell Anatomy 0.000 claims 2
- 230000003053 immunization Effects 0.000 claims 2
- 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 claims 1
- 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 claims 1
- 241000283984 Rodentia Species 0.000 claims 1
- 210000001185 bone marrow Anatomy 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 238000002649 immunization Methods 0.000 claims 1
- 210000001165 lymph node Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 210000000952 spleen Anatomy 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 claims 1
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161446895P | 2011-02-25 | 2011-02-25 | |
| US61/446,895 | 2011-02-25 | ||
| US201161497650P | 2011-06-16 | 2011-06-16 | |
| US61/497,650 | 2011-06-16 | ||
| US201261595200P | 2012-02-06 | 2012-02-06 | |
| US61/595,200 | 2012-02-06 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013550677A Division JP2014507137A (ja) | 2011-02-25 | 2012-02-24 | Ａｄａｍ６マウス |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015036588A Division JP2015107131A (ja) | 2011-02-25 | 2015-02-26 | Ａｄａｍ６マウス |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014110814A JP2014110814A (ja) | 2014-06-19 |
| JP2014110814A5 true JP2014110814A5 (enExample) | 2015-04-09 |
| JP5866127B2 JP5866127B2 (ja) | 2016-02-17 |
Family
ID=45998616
Family Applications (8)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013550677A Pending JP2014507137A (ja) | 2011-02-25 | 2012-02-24 | Ａｄａｍ６マウス |
| JP2014057616A Active JP5866127B2 (ja) | 2011-02-25 | 2014-03-20 | Ａｄａｍ６マウス |
| JP2015036588A Withdrawn JP2015107131A (ja) | 2011-02-25 | 2015-02-26 | Ａｄａｍ６マウス |
| JP2016088848A Withdrawn JP2016135143A (ja) | 2011-02-25 | 2016-04-27 | Ａｄａｍ６マウス |
| JP2018107070A Withdrawn JP2018143250A (ja) | 2011-02-25 | 2018-06-04 | Ａｄａｍ６マウス |
| JP2019127562A Withdrawn JP2019187446A (ja) | 2011-02-25 | 2019-07-09 | Ａｄａｍ６マウス |
| JP2022029501A Pending JP2022071051A (ja) | 2011-02-25 | 2022-02-28 | Ａｄａｍ６マウス |
| JP2024212173A Pending JP2025032218A (ja) | 2011-02-25 | 2024-12-05 | Ａｄａｍ６マウス |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013550677A Pending JP2014507137A (ja) | 2011-02-25 | 2012-02-24 | Ａｄａｍ６マウス |
Family Applications After (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015036588A Withdrawn JP2015107131A (ja) | 2011-02-25 | 2015-02-26 | Ａｄａｍ６マウス |
| JP2016088848A Withdrawn JP2016135143A (ja) | 2011-02-25 | 2016-04-27 | Ａｄａｍ６マウス |
| JP2018107070A Withdrawn JP2018143250A (ja) | 2011-02-25 | 2018-06-04 | Ａｄａｍ６マウス |
| JP2019127562A Withdrawn JP2019187446A (ja) | 2011-02-25 | 2019-07-09 | Ａｄａｍ６マウス |
| JP2022029501A Pending JP2022071051A (ja) | 2011-02-25 | 2022-02-28 | Ａｄａｍ６マウス |
| JP2024212173A Pending JP2025032218A (ja) | 2011-02-25 | 2024-12-05 | Ａｄａｍ６マウス |
Country Status (31)
| Country | Link |
|---|---|
| US (12) | US8642835B2 (enExample) |
| EP (7) | EP4067496B1 (enExample) |
| JP (8) | JP2014507137A (enExample) |
| KR (1) | KR101387377B1 (enExample) |
| CN (2) | CN105861548B (enExample) |
| AU (6) | AU2012243291B2 (enExample) |
| BR (1) | BR112013021771B1 (enExample) |
| CA (1) | CA2820824A1 (enExample) |
| CY (5) | CY1116301T1 (enExample) |
| DE (5) | DE12716101T1 (enExample) |
| DK (6) | DK2738259T3 (enExample) |
| ES (6) | ES2748832T5 (enExample) |
| FI (3) | FI2578688T4 (enExample) |
| HR (5) | HRP20150262T1 (enExample) |
| HU (5) | HUE047687T2 (enExample) |
| IL (4) | IL226727A (enExample) |
| IN (1) | IN2013CN07629A (enExample) |
| LT (4) | LT4067496T (enExample) |
| ME (3) | ME03732B (enExample) |
| MX (3) | MX343009B (enExample) |
| MY (1) | MY172713A (enExample) |
| NZ (2) | NZ776770A (enExample) |
| PL (5) | PL2738258T5 (enExample) |
| PT (5) | PT2550363E (enExample) |
| RS (5) | RS59929B1 (enExample) |
| RU (2) | RU2582261C2 (enExample) |
| SG (4) | SG10201913155QA (enExample) |
| SI (5) | SI2550363T1 (enExample) |
| SM (5) | SMT201900744T1 (enExample) |
| WO (1) | WO2012141798A1 (enExample) |
| ZA (1) | ZA201305998B (enExample) |
Families Citing this family (95)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050144655A1 (en) | 2000-10-31 | 2005-06-30 | Economides Aris N. | Methods of modifying eukaryotic cells |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| USRE47770E1 (en) | 2002-07-18 | 2019-12-17 | Merus N.V. | Recombinant production of mixtures of antibodies |
| NZ537277A (en) | 2002-07-18 | 2008-04-30 | Crucell Holland Bv | Recombinant production of mixtures of antibodies |
| US20100069614A1 (en) | 2008-06-27 | 2010-03-18 | Merus B.V. | Antibody producing non-human mammals |
| WO2004106375A1 (en) | 2003-05-30 | 2004-12-09 | Merus Biopharmaceuticals B.V. I.O. | Fab library for the preparation of anti vegf and anti rabies virus fabs |
| EP1776383B1 (en) | 2004-07-22 | 2014-08-20 | Erasmus University Medical Center Rotterdam | Binding molecules |
| GB0905023D0 (en) | 2009-03-24 | 2009-05-06 | Univ Erasmus Medical Ct | Binding molecules |
| US9445581B2 (en) | 2012-03-28 | 2016-09-20 | Kymab Limited | Animal models and therapeutic molecules |
| DK3241435T3 (da) | 2009-07-08 | 2021-08-23 | Kymab Ltd | Dyremodeller og terapeutiske molekyler |
| US20130045492A1 (en) | 2010-02-08 | 2013-02-21 | Regeneron Pharmaceuticals, Inc. | Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain |
| US9796788B2 (en) | 2010-02-08 | 2017-10-24 | Regeneron Pharmaceuticals, Inc. | Mice expressing a limited immunoglobulin light chain repertoire |
| SG183149A1 (en) | 2010-02-08 | 2012-09-27 | Regeneron Pharma | Common light chain mouse |
| EP2601298B1 (en) | 2010-08-02 | 2016-11-30 | Regeneron Pharmaceuticals, Inc. | Mice that make binding proteins comprising vl domains |
| CN105861548B (zh) | 2011-02-25 | 2020-01-10 | 瑞泽恩制药公司 | Adam6小鼠 |
| US10040826B2 (en) | 2011-07-05 | 2018-08-07 | Duke University | Human immunodeficiency virus type 1 (HIV-1) N-terminal deleted GP120 immunogens |
| ES2872081T3 (es) | 2011-08-05 | 2021-11-02 | Regeneron Pharma | Ratones con cadena ligera universal humanizada |
| WO2013041845A2 (en) | 2011-09-19 | 2013-03-28 | Kymab Limited | Animals, repertoires & methods |
| AU2012311286B2 (en) * | 2011-09-19 | 2018-07-26 | Kymab Limited | Antibodies, variable domains and chains tailored for human use |
| WO2013045916A1 (en) | 2011-09-26 | 2013-04-04 | Kymab Limited | Chimaeric surrogate light chains (slc) comprising human vpreb |
| EP2763699A4 (en) | 2011-10-03 | 2015-05-20 | Univ Duke | VACCINE |
| EP4074833A1 (en) | 2011-10-17 | 2022-10-19 | Regeneron Pharmaceuticals, Inc. | Restricted immunoglobulin heavy chain mice |
| US20180295821A1 (en) * | 2011-12-02 | 2018-10-18 | Kymab Limited | Transgenic Animals |
| GB201122047D0 (en) * | 2011-12-21 | 2012-02-01 | Kymab Ltd | Transgenic animals |
| US9253965B2 (en) * | 2012-03-28 | 2016-02-09 | Kymab Limited | Animal models and therapeutic molecules |
| SMT201900296T1 (it) | 2011-12-20 | 2019-07-11 | Regeneron Pharma | Topi di catena leggera umanizzata |
| RU2664185C2 (ru) * | 2012-02-01 | 2018-08-15 | Регенерон Фармасьютикалз, Инк. | Гуманизированные грызуны, которые экспрессируют тяжелые цепи, содержащие домены vl |
| WO2013138681A1 (en) | 2012-03-16 | 2013-09-19 | Regeneron Pharmaceuticals, Inc. | Mice that produce antigen-binding proteins with ph-dependent binding characteristics |
| US9801362B2 (en) | 2012-03-16 | 2017-10-31 | Regeneron Pharmaceuticals, Inc. | Non-human animals expressing pH-sensitive immunoglobulin sequences |
| US20140013456A1 (en) | 2012-03-16 | 2014-01-09 | Regeneron Pharmaceuticals, Inc. | Histidine Engineered Light Chain Antibodies and Genetically Modified Non-Human Animals for Generating the Same |
| HUE037659T2 (hu) | 2012-03-16 | 2018-09-28 | Regeneron Pharma | Hisztidinmódosított könnyûlánc antitestek és genetikailag módosított rágcsálók ennek az elõállítására |
| US10251377B2 (en) | 2012-03-28 | 2019-04-09 | Kymab Limited | Transgenic non-human vertebrate for the expression of class-switched, fully human, antibodies |
| GB2502127A (en) | 2012-05-17 | 2013-11-20 | Kymab Ltd | Multivalent antibodies and in vivo methods for their production |
| WO2013157953A1 (en) | 2012-04-20 | 2013-10-24 | Merus B.V. | Methods and means for the production of ig-like molecules |
| NZ703689A (en) * | 2012-06-12 | 2016-05-27 | Regeneron Pharma | Humanized non-human animals with restricted immunoglobulin heavy chain loci |
| SG11201505713YA (en) | 2013-02-06 | 2015-08-28 | Regeneron Pharma | B cell lineage based immunogen design with humanized animals |
| RS57582B1 (sr) | 2013-02-20 | 2018-11-30 | Regeneron Pharma | Nehumane životinje sa modifikovanim sekvencama imunoglobulinskog teškog lanca |
| PL2967012T3 (pl) * | 2013-03-14 | 2021-04-19 | Erasmus University Medical Center Rotterdam | Transgeniczne ssaki inne niż człowiek do wytwarzania przeciwciał |
| US10993420B2 (en) | 2013-03-15 | 2021-05-04 | Erasmus University Medical Center | Production of heavy chain only antibodies in transgenic mammals |
| US9788534B2 (en) | 2013-03-18 | 2017-10-17 | Kymab Limited | Animal models and therapeutic molecules |
| US9783618B2 (en) | 2013-05-01 | 2017-10-10 | Kymab Limited | Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics |
| US11707056B2 (en) * | 2013-05-02 | 2023-07-25 | Kymab Limited | Animals, repertoires and methods |
| US9783593B2 (en) | 2013-05-02 | 2017-10-10 | Kymab Limited | Antibodies, variable domains and chains tailored for human use |
| WO2015049517A2 (en) | 2013-10-01 | 2015-04-09 | Kymab Limited | Animal models and therapeutic molecules |
| JP6267986B2 (ja) * | 2014-02-13 | 2018-01-24 | 株式会社特殊免疫研究所 | ヒトの特定分子と結合する分子標的物質のｉｎｖｉｖｏ評価法 |
| SG10201808083VA (en) | 2014-03-21 | 2018-10-30 | Regeneron Pharma | Vl antigen binding proteins exhibiting distinct binding characteristics |
| AU2015230938C1 (en) * | 2014-03-21 | 2021-10-14 | Regeneron Pharmaceuticals, Inc. | Non-human animals that make single domain binding proteins |
| US20160081314A1 (en) | 2014-09-19 | 2016-03-24 | Regeneron Pharmaceuticals, Inc. | Chimeric Antigen Receptors |
| CN107438622A (zh) | 2015-03-19 | 2017-12-05 | 瑞泽恩制药公司 | 选择结合抗原的轻链可变区的非人动物 |
| TWI824372B (zh) | 2015-10-12 | 2023-12-01 | 美商再生元醫藥公司 | 活化瘦素受體的抗原結合蛋白 |
| US20190037816A1 (en) | 2016-01-13 | 2019-02-07 | Regeneron Pharmaceuticals, Inc. | Rodents having an engineered heavy chain diversity region |
| JP2019509059A (ja) | 2016-02-16 | 2019-04-04 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | 変異型キヌレニナーゼ遺伝子を有する非ヒト動物 |
| SG10202102885UA (en) * | 2016-05-20 | 2021-05-28 | Regeneron Pharma | Methods for breaking immunological tolerance using multiple guide rnas |
| CN109640644B (zh) | 2016-06-03 | 2021-10-26 | 瑞泽恩制药公司 | 表达外源末端脱氧核苷酸转移酶的非人动物 |
| WO2017214089A1 (en) | 2016-06-06 | 2017-12-14 | Regeneron Pharmaceuticals, Inc. | Non-human animals expressing antibodies with human lambda light chains |
| EP4567119A3 (en) | 2016-11-04 | 2025-09-24 | Regeneron Pharmaceuticals, Inc. | Non-human animals having an engineered immunoglobulin lambda light chain locus |
| US11122042B1 (en) | 2017-05-12 | 2021-09-14 | F5 Networks, Inc. | Methods for dynamically managing user access control and devices thereof |
| AU2018281280B2 (en) | 2017-06-07 | 2024-12-19 | Regeneron Pharmaceuticals, Inc. | Compositions and methods for internalizing enzymes |
| GB201710984D0 (en) | 2017-07-07 | 2017-08-23 | Kymab Ltd | Cells, vertebrates, populations & methods |
| WO2019113065A1 (en) | 2017-12-05 | 2019-06-13 | Regeneron Pharmaceuticals, Inc. | Non-human animals having an engineered immunoglobulin lambda light chain and uses thereof |
| CN112040985A (zh) | 2018-02-07 | 2020-12-04 | 瑞泽恩制药公司 | 用于递送治疗性蛋白质的方法和组合物 |
| ES3076179T3 (en) | 2018-03-21 | 2026-08-12 | Crystal Bioscience Inc | Transgenic chicken that produces human antibodies |
| EP4534560A3 (en) | 2018-03-24 | 2025-06-11 | Regeneron Pharmaceuticals, Inc. | Genetically modified non-human animals for generating therapeutic antibodies against peptide-mhc complexes, methods of making and uses thereof |
| IL277355B2 (en) | 2018-03-26 | 2025-01-01 | Regeneron Pharma | Humanized rodents for testing therapeutic agents |
| SMT202500283T1 (it) | 2018-04-06 | 2025-09-12 | Regeneron Pharma | Un anticorpo agonista del recettore della leptina da utilizzare per aumentare la massa ossea in un soggetto affetto da disfunzione metabolica o ipoleptinemia |
| EP3793591A1 (en) | 2018-05-17 | 2021-03-24 | Regeneron Pharmaceuticals, Inc. | Anti-cd63 antibodies, conjugates, and uses thereof |
| WO2019240999A1 (en) * | 2018-06-13 | 2019-12-19 | Crystal Bioscience Inc. | Camelization of a human variable domain by gene conversion |
| IL318469A (en) | 2018-06-14 | 2025-03-01 | Regeneron Pharma | Non-human animals capable of reorganizing transgenic DH-DH, and their uses |
| WO2020169022A1 (en) | 2019-02-18 | 2020-08-27 | Beijing Biocytogen Co., Ltd | Genetically modified non-human animals with humanized immunoglobulin locus |
| BR112021016173A2 (pt) | 2019-02-22 | 2021-11-03 | Regeneron Pharma | Roedor geneticamente modificado, métodos de produção de um roedor geneticamente modificado e de produção de um anticorpo anti-nav1.7, célula ou tecido isolado de roedor, linhagem celular imortalizada, embrião de roedor, construto de ácido nucleico de direcionamento, e, hibridoma |
| PT3979790T (pt) | 2019-06-05 | 2026-05-05 | Regeneron Pharma | Roedores possuindo um reportrio limitado de cadeias leves lambda expressadas a partir do lcus kappa e suas utilizaes |
| EP3785536B2 (en) * | 2019-08-28 | 2025-09-17 | Trianni, Inc. | Adam6 knockin mice |
| WO2021113297A1 (en) | 2019-12-02 | 2021-06-10 | Regeneron Pharmaceuticals, Inc. | Peptide-mhc ii protein constructs and uses thereof |
| CN115667532A (zh) | 2020-06-02 | 2023-01-31 | 百奥赛图(北京)医药科技股份有限公司 | 具有共有轻链免疫球蛋白基因座的经遗传修饰的非人动物 |
| US20220090060A1 (en) | 2020-09-11 | 2022-03-24 | Regeneron Pharmaceuticals, Inc. | Identification and production of antigen-specific antibodies |
| EP4262373A1 (en) | 2020-12-16 | 2023-10-25 | Regeneron Pharmaceuticals, Inc. | Mice expressing humanized fc alpha receptors |
| MX2023007401A (es) | 2020-12-23 | 2023-07-06 | Regeneron Pharma | Acidos nucleicos que codifican anticuerpos modificados por anclaje y usos de los mismos. |
| CA3197426A1 (en) | 2020-12-23 | 2022-06-30 | Regeneron Pharmaceuticals, Inc. | Methods for obtaining antibodies that bind transmembrane proteins and cells that produce the same |
| AU2022261074B2 (en) | 2021-04-20 | 2026-07-23 | Regeneron Pharmaceuticals, Inc. | Human antibodies to artemin and methods of use thereof |
| WO2024015816A1 (en) | 2022-07-12 | 2024-01-18 | Regeneron Pharmaceuticals, Inc. | Antibodies to ciliary neurotrophic factor receptor (cntfr) and methods of use thereof |
| WO2024173248A1 (en) | 2023-02-13 | 2024-08-22 | Regeneron Pharmaceuticals, Inc. | Treatment of muscle related disorders with anti-human cacng1 antibodies |
| CN121039163A (zh) | 2023-05-02 | 2025-11-28 | 瑞泽恩制药公司 | 抗人m-钙粘蛋白（cdh15）抗体、缀合物及其用于将遗传有效负载递送至肌肉细胞的用途 |
| IL325400A (en) | 2023-07-10 | 2026-02-01 | Regeneron Pharma | Anti-human CACNG1 antibody-drug conjugates and their uses |
| WO2025055311A1 (zh) * | 2023-09-15 | 2025-03-20 | 赛业（苏州）生物科技有限公司 | 用于制备抗体的基因修饰小鼠及其制备方法 |
| CN120035380A (zh) * | 2023-09-15 | 2025-05-23 | 赛业（苏州）生物科技有限公司 | 用于制备抗体的基因修饰小鼠及其制备方法 |
| WO2025064738A1 (en) | 2023-09-22 | 2025-03-27 | Regeneron Pharmaceuticals, Inc. | Dntt 250-258 off-target peptides and uses thereof |
| WO2025064761A1 (en) | 2023-09-22 | 2025-03-27 | Regeneron Pharmaceuticals, Inc. | Kras10-18 g12d off-target peptides and uses thereof |
| CN118339300A (zh) * | 2024-01-02 | 2024-07-12 | 江苏集萃药康生物科技股份有限公司 | 产生人源化抗体的动物模型及其构建方法 |
| CN120813244A (zh) | 2024-02-07 | 2025-10-17 | 赛业（苏州）生物科技有限公司 | 用于制备抗体的基因修饰小鼠及其制备方法 |
| CN121002186A (zh) | 2024-02-07 | 2025-11-21 | 赛业（苏州）生物科技有限公司 | 用于制备抗体的基因修饰小鼠及其制备方法 |
| WO2026006724A1 (en) | 2024-06-28 | 2026-01-02 | Regeneron Pharmaceuticals, Inc. | Prame off-target peptides and uses thereof |
| WO2026006734A1 (en) | 2024-06-28 | 2026-01-02 | Regeneron Pharmaceuticals, Inc. | Off-target peptide-mhc complex conformation modeling systems and methods for antigen-recognition molecule development |
| WO2026030428A2 (en) | 2024-08-01 | 2026-02-05 | Regeneron Pharmaceuticals, Inc. | Prostate-specific antigen peptides and uses thereof |
| US20260123608A1 (en) | 2024-08-06 | 2026-05-07 | Regeneron Pharmaceuticals, Inc. | Non-human animals having modified immunoglobulin heavy chain constant region locus and uses thereof |
| WO2026096736A1 (en) | 2024-10-31 | 2026-05-07 | Regeneron Pharmaceuticals, Inc. | Rodents expressing humanized polymeric immunoglobulin receptor |
Family Cites Families (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| WO1991000906A1 (en) | 1989-07-12 | 1991-01-24 | Genetics Institute, Inc. | Chimeric and transgenic animals capable of producing human antibodies |
| US6657103B1 (en) | 1990-01-12 | 2003-12-02 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US6673986B1 (en) | 1990-01-12 | 2004-01-06 | Abgenix, Inc. | Generation of xenogeneic antibodies |
| US7041871B1 (en) | 1995-10-10 | 2006-05-09 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| RU2151612C1 (ru) * | 1992-12-01 | 2000-06-27 | Протеин Дизайн Лэбс, Инк. | Гуманизированный иммуноглобулин, специфичный для белка l-селектина человека |
| EP1972194A1 (en) * | 1996-12-03 | 2008-09-24 | Amgen Fremont Inc. | Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom |
| CN1203922A (zh) * | 1997-03-21 | 1999-01-06 | 三共株式会社 | 人源化抗人fas抗体 |
| US20020062010A1 (en) | 1997-05-02 | 2002-05-23 | Genentech, Inc. | Method for making multispecific antibodies having heteromultimeric and common components |
| RU10506U1 (ru) | 1999-04-08 | 1999-08-16 | Кривулин Виталий Николаевич | Ручной культиватор |
| WO2000073323A2 (en) * | 1999-05-27 | 2000-12-07 | Human Genome Sciences, Inc. | Adam polynucleotides and polypeptides |
| GB0001448D0 (en) * | 2000-01-21 | 2000-03-08 | Novartis Ag | Organic compounds |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| US7105348B2 (en) | 2000-10-31 | 2006-09-12 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| US6586251B2 (en) | 2000-10-31 | 2003-07-01 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| PE20020574A1 (es) | 2000-12-06 | 2002-07-02 | Wyeth Corp | Anticuerpos humanizados que reconocen el peptido amiloideo beta |
| US7034134B2 (en) | 2001-04-26 | 2006-04-25 | Bristol-Myers Squibb Company | Polynucleotide encoding a novel metalloprotease highly expressed in the testis, MMP-29 |
| AU2002309063B8 (en) | 2001-05-11 | 2008-04-24 | Kyowa Kirin Co., Ltd. | Artificial human chromosome containing human antibody lambda light chain gene |
| US7473557B2 (en) | 2001-06-06 | 2009-01-06 | Regeneron Pharmaceuticals, Inc. | Method for targeting transcriptionally active loci |
| US20060199204A1 (en) | 2001-10-05 | 2006-09-07 | U.S. Epa | Genetic testing for male factor infertility |
| WO2003031656A1 (en) | 2001-10-05 | 2003-04-17 | United States Environmental Protection Agency | Genetic testing for male factor infertility |
| JP4099646B2 (ja) | 2002-06-04 | 2008-06-11 | 株式会社安川電機 | ボイスコイルモータ |
| NZ537277A (en) | 2002-07-18 | 2008-04-30 | Crucell Holland Bv | Recombinant production of mixtures of antibodies |
| RU2251699C1 (ru) | 2003-09-25 | 2005-05-10 | Киселев Всеволод Иванович | Способ ранней и доклинической диагностики цервикального рака |
| EP1802193B1 (en) | 2004-10-19 | 2014-04-30 | Regeneron Pharmaceuticals, Inc. | Method for generating a mouse homozygous for a genetic modification |
| ES2318384T3 (es) | 2005-06-30 | 2009-05-01 | Borealis Technology Oy | Capa exterior de funda para cables de potencia o de comuniccion. |
| JP5514539B2 (ja) | 2006-03-31 | 2014-06-04 | メダレックス・リミテッド・ライアビリティ・カンパニー | ヒト抗体の調製に用いるためのキメラ抗体を発現するトランスジェニック動物 |
| ATE537190T1 (de) | 2006-06-02 | 2011-12-15 | Regeneron Pharma | Hochaffine antikörper gegen den humanen il-6- rezeptor |
| JP5588866B2 (ja) | 2007-08-10 | 2014-09-10 | メダレックス エル．エル．シー． | Ｈｃｏ３２およびｈｃｏ２７、ならびに関連実施例 |
| US7659842B2 (en) | 2007-10-24 | 2010-02-09 | Infineon Technologies Ag | Quantization error reduction in PWM full-MASH converters |
| PL2346994T3 (pl) | 2008-09-30 | 2022-04-19 | Ablexis, Llc | Myszy knock-in do wytwarzania chimerycznych przeciwciał |
| KR101711222B1 (ko) * | 2008-12-18 | 2017-02-28 | 에라스무스 유니버시티 메디컬 센터 로테르담 | 인간화 항체들을 발현하는 비-인간 유전자이식 동물들 및 그의 이용 |
| GB0905023D0 (en) | 2009-03-24 | 2009-05-06 | Univ Erasmus Medical Ct | Binding molecules |
| JP5399140B2 (ja) * | 2009-06-18 | 2014-01-29 | 株式会社タイトー | モールス信号通信システム |
| DK3241435T3 (da) | 2009-07-08 | 2021-08-23 | Kymab Ltd | Dyremodeller og terapeutiske molekyler |
| WO2011072204A1 (en) | 2009-12-10 | 2011-06-16 | Regeneron Pharmaceuticals, Inc. | Mice that make heavy chain antibodies |
| SG183149A1 (en) | 2010-02-08 | 2012-09-27 | Regeneron Pharma | Common light chain mouse |
| US20120021409A1 (en) | 2010-02-08 | 2012-01-26 | Regeneron Pharmaceuticals, Inc. | Common Light Chain Mouse |
| CN103228130B (zh) * | 2010-06-17 | 2016-03-16 | 科马布有限公司 | 动物模型及治疗分子 |
| CN105861548B (zh) | 2011-02-25 | 2020-01-10 | 瑞泽恩制药公司 | Adam6小鼠 |
| ES2872081T3 (es) | 2011-08-05 | 2021-11-02 | Regeneron Pharma | Ratones con cadena ligera universal humanizada |
| EP4074833A1 (en) | 2011-10-17 | 2022-10-19 | Regeneron Pharmaceuticals, Inc. | Restricted immunoglobulin heavy chain mice |
| GB201118579D0 (en) | 2011-10-27 | 2011-12-07 | Micromass Ltd | Control of ion populations |
| GB201122047D0 (en) | 2011-12-21 | 2012-02-01 | Kymab Ltd | Transgenic animals |
| US9253965B2 (en) | 2012-03-28 | 2016-02-09 | Kymab Limited | Animal models and therapeutic molecules |
| SMT201900296T1 (it) | 2011-12-20 | 2019-07-11 | Regeneron Pharma | Topi di catena leggera umanizzata |
| NZ703689A (en) | 2012-06-12 | 2016-05-27 | Regeneron Pharma | Humanized non-human animals with restricted immunoglobulin heavy chain loci |
-
2012
- 2012-02-24 CN CN201610204885.6A patent/CN105861548B/zh active Active
- 2012-02-24 DE DE12716101T patent/DE12716101T1/de active Pending
- 2012-02-24 HR HRP20150262AT patent/HRP20150262T1/hr unknown
- 2012-02-24 PL PL14154918.8T patent/PL2738258T5/pl unknown
- 2012-02-24 LT LTEP22156414.9T patent/LT4067496T/lt unknown
- 2012-02-24 PL PL14154967T patent/PL2738259T3/pl unknown
- 2012-02-24 ES ES12192727T patent/ES2748832T5/es active Active
- 2012-02-24 SI SI201230157T patent/SI2550363T1/sl unknown
- 2012-02-24 US US13/404,075 patent/US8642835B2/en active Active
- 2012-02-24 HR HRP20192311TT patent/HRP20192311T4/hr unknown
- 2012-02-24 HU HUE14154967A patent/HUE047687T2/hu unknown
- 2012-02-24 PT PT12716101T patent/PT2550363E/pt unknown
- 2012-02-24 CN CN201280010457.XA patent/CN103429746B/zh active Active
- 2012-02-24 HU HUE12192727A patent/HUE046081T2/hu unknown
- 2012-02-24 DK DK14154967.5T patent/DK2738259T3/da active
- 2012-02-24 MX MX2013009649A patent/MX343009B/es active IP Right Grant
- 2012-02-24 LT LT12192727T patent/LT2578688T/lt unknown
- 2012-02-24 ES ES14176593T patent/ES2805364T3/es active Active
- 2012-02-24 RS RS20200177A patent/RS59929B1/sr unknown
- 2012-02-24 HR HRP20191895TT patent/HRP20191895T4/hr unknown
- 2012-02-24 ME MEP-2020-41A patent/ME03732B/me unknown
- 2012-02-24 EP EP22156414.9A patent/EP4067496B1/en active Active
- 2012-02-24 EP EP14154918.8A patent/EP2738258B2/en active Active
- 2012-02-24 DE DE14154918.8T patent/DE14154918T1/de active Pending
- 2012-02-24 RU RU2013125717/10A patent/RU2582261C2/ru active
- 2012-02-24 SG SG10201913155QA patent/SG10201913155QA/en unknown
- 2012-02-24 ES ES22156414T patent/ES2946169T3/es active Active
- 2012-02-24 WO PCT/US2012/026416 patent/WO2012141798A1/en not_active Ceased
- 2012-02-24 EP EP14154967.5A patent/EP2738259B1/en active Active
- 2012-02-24 JP JP2013550677A patent/JP2014507137A/ja active Pending
- 2012-02-24 PT PT221564149T patent/PT4067496T/pt unknown
- 2012-02-24 KR KR1020137025191A patent/KR101387377B1/ko active Active
- 2012-02-24 LT LTEP14154918.8T patent/LT2738258T/lt unknown
- 2012-02-24 ME MEP-2015-35A patent/ME02106B/me unknown
- 2012-02-24 MX MX2016013717A patent/MX375115B/es unknown
- 2012-02-24 PT PT141549675T patent/PT2738259T/pt unknown
- 2012-02-24 RS RS20191599A patent/RS59661B2/sr unknown
- 2012-02-24 DE DE12192727T patent/DE12192727T1/de active Pending
- 2012-02-24 PT PT121927271T patent/PT2578688T/pt unknown
- 2012-02-24 CA CA2820824A patent/CA2820824A1/en not_active Withdrawn
- 2012-02-24 BR BR112013021771-5A patent/BR112013021771B1/pt active IP Right Grant
- 2012-02-24 SI SI201232031T patent/SI4067496T1/sl unknown
- 2012-02-24 RU RU2016109443A patent/RU2722373C2/ru not_active Application Discontinuation
- 2012-02-24 EP EP14176593.3A patent/EP2813573B1/en active Active
- 2012-02-24 SG SG10201405135RA patent/SG10201405135RA/en unknown
- 2012-02-24 RS RS20230475A patent/RS64280B1/sr unknown
- 2012-02-24 SM SM20190744T patent/SMT201900744T1/it unknown
- 2012-02-24 RS RS20150163A patent/RS53880B1/sr unknown
- 2012-02-24 DE DE14154967.5T patent/DE14154967T1/de active Pending
- 2012-02-24 MY MYPI2013003123A patent/MY172713A/en unknown
- 2012-02-24 RS RS20191337A patent/RS59413B2/sr unknown
- 2012-02-24 NZ NZ776770A patent/NZ776770A/en unknown
- 2012-02-24 DE DE14176593.3T patent/DE14176593T1/de active Pending
- 2012-02-24 ES ES12716101.6T patent/ES2532487T3/es active Active
- 2012-02-24 HU HUE14154918A patent/HUE046746T2/hu unknown
- 2012-02-24 SI SI201231739T patent/SI2738259T1/sl unknown
- 2012-02-24 SG SG10201913160QA patent/SG10201913160QA/en unknown
- 2012-02-24 SI SI201231675T patent/SI2578688T2/sl unknown
- 2012-02-24 EP EP12716101.6A patent/EP2550363B1/en active Active
- 2012-02-24 PL PL12716101T patent/PL2550363T3/pl unknown
- 2012-02-24 AU AU2012243291A patent/AU2012243291B2/en active Active
- 2012-02-24 FI FIEP12192727.1T patent/FI2578688T4/fi active
- 2012-02-24 PL PL22156414.9T patent/PL4067496T3/pl unknown
- 2012-02-24 IN IN7629CHN2013 patent/IN2013CN07629A/en unknown
- 2012-02-24 DK DK22156414.9T patent/DK4067496T5/da active
- 2012-02-24 EP EP12192727.1A patent/EP2578688B2/en active Active
- 2012-02-24 LT LTEP14154967.5T patent/LT2738259T/lt unknown
- 2012-02-24 PT PT141549188T patent/PT2738258T/pt unknown
- 2012-02-24 DK DK12192727.1T patent/DK2578688T4/da active
- 2012-02-24 DK DK14176593.3T patent/DK2813573T1/da unknown
- 2012-02-24 FI FIEP14154918.8T patent/FI2738258T4/fi active
- 2012-02-24 SM SM20230173T patent/SMT202300173T1/it unknown
- 2012-02-24 ES ES14154967T patent/ES2770424T3/es active Active
- 2012-02-24 DK DK12716101.6T patent/DK2550363T3/en active
- 2012-02-24 DK DK14154918.8T patent/DK2738258T4/da active
- 2012-02-24 NZ NZ731926A patent/NZ731926A/en unknown
- 2012-02-24 HU HUE22156414A patent/HUE062552T2/hu unknown
- 2012-02-24 ME MEP2019272 patent/ME03537B/xx unknown
- 2012-02-24 EP EP20170540.7A patent/EP3744850A1/en active Pending
- 2012-02-24 SI SI201231712T patent/SI2738258T2/sl unknown
- 2012-02-24 SG SG2013064159A patent/SG192933A1/en unknown
- 2012-02-24 SM SM20190581T patent/SMT201900581T1/it unknown
- 2012-02-24 HR HRP20230526TT patent/HRP20230526T1/hr unknown
- 2012-02-24 SM SM20200112T patent/SMT202000112T1/it unknown
- 2012-02-24 PL PL12192727.1T patent/PL2578688T5/pl unknown
- 2012-02-24 ES ES14154918T patent/ES2758974T5/es active Active
- 2012-02-24 HU HUE12716101A patent/HUE024534T2/hu unknown
-
2013
- 2013-05-09 US US13/890,519 patent/US8697940B2/en active Active
- 2013-06-04 IL IL226727A patent/IL226727A/en active IP Right Grant
- 2013-08-08 ZA ZA2013/05998A patent/ZA201305998B/en unknown
- 2013-08-21 MX MX2020009714A patent/MX2020009714A/es unknown
-
2014
- 2014-02-27 US US14/192,051 patent/US9932408B2/en active Active
- 2014-03-20 JP JP2014057616A patent/JP5866127B2/ja active Active
-
2015
- 2015-01-20 US US14/600,829 patent/US10072095B2/en active Active
- 2015-02-26 JP JP2015036588A patent/JP2015107131A/ja not_active Withdrawn
- 2015-03-03 CY CY20151100221T patent/CY1116301T1/el unknown
- 2015-03-11 SM SM201500061T patent/SMT201500061B/xx unknown
- 2015-04-09 US US14/682,859 patent/US9944716B2/en active Active
- 2015-10-07 AU AU2015238806A patent/AU2015238806A1/en not_active Abandoned
-
2016
- 2016-04-27 JP JP2016088848A patent/JP2016135143A/ja not_active Withdrawn
-
2017
- 2017-10-26 AU AU2017251802A patent/AU2017251802A1/en not_active Abandoned
-
2018
- 2018-06-04 JP JP2018107070A patent/JP2018143250A/ja not_active Withdrawn
- 2018-08-09 US US16/059,922 patent/US10905109B2/en active Active
- 2018-08-09 US US16/059,884 patent/US10694725B2/en active Active
- 2018-08-09 US US16/059,821 patent/US10905108B2/en active Active
- 2018-08-09 US US16/059,871 patent/US10577430B2/en active Active
- 2018-08-20 IL IL261243A patent/IL261243B/en active IP Right Grant
-
2019
- 2019-07-09 JP JP2019127562A patent/JP2019187446A/ja not_active Withdrawn
- 2019-08-13 IL IL268671A patent/IL268671B/en active IP Right Grant
- 2019-09-19 CY CY20191100988T patent/CY1122205T1/el unknown
- 2019-10-23 CY CY20191101104T patent/CY1122459T1/el unknown
-
2020
- 2020-01-22 CY CY20201100054T patent/CY1122820T1/el unknown
- 2020-02-21 AU AU2020201279A patent/AU2020201279A1/en not_active Abandoned
- 2020-02-21 HR HRP20200294TT patent/HRP20200294T1/hr unknown
- 2020-04-16 IL IL273986A patent/IL273986B/en active IP Right Grant
- 2020-12-21 US US17/129,708 patent/US11950578B2/en active Active
- 2020-12-21 US US17/129,706 patent/US12207628B2/en active Active
-
2022
- 2022-02-11 FI FIEP22156414.9T patent/FI4067496T3/fi active
- 2022-02-28 JP JP2022029501A patent/JP2022071051A/ja active Pending
- 2022-07-22 AU AU2022206806A patent/AU2022206806B2/en active Active
-
2023
- 2023-05-31 CY CY20231100256T patent/CY1126091T1/el unknown
-
2024
- 2024-03-06 US US18/597,797 patent/US20240306617A1/en active Pending
- 2024-12-05 JP JP2024212173A patent/JP2025032218A/ja active Pending
-
2025
- 2025-12-17 AU AU2025283466A patent/AU2025283466A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2014127339A (ru) | Мыши с гуманизированной легкой цепью | |
| JP2015505477A5 (enExample) | ||
| RU2014153673A (ru) | Гуманизированные не относящиеся к человеку животные с ограниченными локусами тяжелой цепи иммуноглобулина | |
| RU2014133653A (ru) | Гуманизированные грызуны, которые экспрессируют тяжелые цепи, содержащие домены vl | |
| JP2021137030A5 (enExample) | ||
| JP2015525071A5 (enExample) | ||
| JP2015519076A5 (enExample) | ||
| JP2015502177A5 (enExample) | ||
| RU2016109443A (ru) | Мыши adam6 | |
| JP2018138047A5 (enExample) | ||
| JP2016512034A5 (enExample) | ||
| JP2019083823A5 (enExample) | ||
| JP2012532598A5 (enExample) | ||
| RU2019112589A (ru) | Отличные от человека животные со сконструированным локусом легкой лямбда-цепи иммуноглобулина | |
| JP2020530760A5 (enExample) | ||
| JP2015519055A5 (enExample) | ||
| WO2014160202A4 (en) | Mice expressing a limited immunoglobulin light chain repertoire | |
| RU2016141307A (ru) | Отличные от человека животные, которые вырабатывают однодоменные связывающие белки | |
| JP2014524243A5 (enExample) | ||
| HUE029785T2 (en) | Common light chain mouse | |
| JP2015509380A5 (enExample) | ||
| JP2015534819A5 (enExample) | ||
| JP2013535213A5 (enExample) | ||
| JP2013198489A5 (enExample) | ||
| HUE034386T2 (en) | Production of binding molecules |